Does ARIPIPRAZOLE Cause Stent placement? 29 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Stent placement have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.0% of all adverse event reports for ARIPIPRAZOLE.
29
Reports of Stent placement with ARIPIPRAZOLE
0.0%
of all ARIPIPRAZOLE reports
10
Deaths
18
Hospitalizations
How Dangerous Is Stent placement From ARIPIPRAZOLE?
Of the 29 reports, 10 (34.5%) resulted in death, 18 (62.1%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which ARIPIPRAZOLE Alternatives Have Lower Stent placement Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE